Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA016816-11
Application #
3164529
Study Section
Cognition and Perception Study Section (CP)
Project Start
1978-03-01
Project End
1985-08-31
Budget Start
1985-03-01
Budget End
1985-08-31
Support Year
11
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Blatti, S P; Foster, D N; Ranganathan, G et al. (1988) Induction of fibronectin gene transcription and mRNA is a primary response to growth-factor stimulation of AKR-2B cells. Proc Natl Acad Sci U S A 85:1119-23
Goustin, A S; Leof, E B; Shipley, G D et al. (1986) Growth factors and cancer. Cancer Res 46:1015-29
Shipley, G D; Pittelkow, M R; Wille Jr, J J et al. (1986) Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium. Cancer Res 46:2068-71
Leof, E B; Proper, J A; Getz, M J et al. (1986) Transforming growth factor type beta regulation of actin mRNA. J Cell Physiol 127:83-8
Coffey Jr, R J; Shipley, G D; Moses, H L (1986) Production of transforming growth factors by human colon cancer lines. Cancer Res 46:1164-9
Leof, E B; Proper, J A; Goustin, A S et al. (1986) Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci U S A 83:2453-7
Shipley, G D; Tucker, R F; Moses, H L (1985) Type beta transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval. Proc Natl Acad Sci U S A 82:4147-51